Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | United States | $4.44B | 28,292,616 | 75.55% | 24.45% | Net Selling | Net Selling |
| TGTX | TG THERAPEUTICS INC | United States | $2.08B | 154,420,772 | 53.78% | 46.22% | Net Selling | Net Selling |
| GMAB | GENMAB A | Denmark | $18.60B | 66,074,535 | 70.53% | 0.00% | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | United States | $1.66B | 56,769,081 | 61.03% | 38.97% | Net Selling | Net Selling |
| MDXG | MIMEDX GROUP INC | United States | $921.43M | 146,958,420 | 42.42% | 57.58% | Net Buying | Net Selling |
| VNDA | VANDA PHARMACEUTICALS INC | United States | $265.82M | 57,537,499 | 56.23% | 43.77% | Net Selling | Net Selling |
| CORT | CORCEPT THERAPEUTICS INC | United States | $2.36B | 103,517,388 | 30.65% | 69.35% | Net Buying | Net Buying |
| HALO | HALOZYME THERAPEUTICS INC | United States | $4.89B | 126,824,800 | 78.23% | 21.77% | Net Selling | Net Selling |
| RPRX | ROYALTY PHARMA PLC | United States | $16.73B | 597,434,791 | 51.02% | 16.51% | Net Selling | Net Buying |
| INCY | INCYTE CORP | United States | $11.60B | 224,526,128 | 79.30% | 20.70% | Net Selling | Net Buying |
| BMRN | BIOMARIN PHARMACEUTICAL INC | United States | $15.36B | 189,879,803 | 97.46% | 1.62% | Net Selling | Net Selling |
| JAZZ | JAZZ PHARMACEUTICALS PLC | Ireland | $6.82B | 62,345,283 | 26.94% | 73.06% | Net Selling | Net Selling |
| AMLX | AMYLYX PHARMACEUTICALS INC | United States | $119.30M | 67,782,139 | 52.42% | 47.58% | Net Buying | Net Selling |
| EXEL | EXELIXIS INC | United States | $7.19B | 303,194,259 | 85.28% | 4.07% | Net Selling | Net Buying |
| PBYI | PUMA BIOTECHNOLOGY INC | United States | $242.00M | 48,207,162 | 55.20% | 44.43% | Net Selling | |
| TECH | BIO-TECHNE CORP | United States | $10.07B | 157,191,685 | 97.66% | 2.34% | Net Buying | Net Selling |
| BNTX | BIONTECH SE | Germany | $20.73B | 237,725,735 | 17.05% | 0.00% | ||
| CPRX | CATALYST PHARMACEUTICALS INC | United States | $1.75B | 117,863,258 | 71.64% | 16.33% | Net Buying | Net Buying |
| NVO | NOVO NORDISK A S | Denmark | $572.09B | 4,510,000,000 | 6.84% | 0.00% | ||
| UTHR | UNITED THERAPEUTICS CORP | United States | $11.00B | 47,058,545 | 87.59% | 12.41% | Net Selling | Net Selling |
| REGN | REGENERON PHARMACEUTICALS INC | United States | $96.94B | 109,761,896 | 69.39% | 30.61% | Net Selling | Net Buying |
| VRTX | VERTEX PHARMACEUTICALS INC | United States | $102.67B | 258,307,816 | 90.91% | 1.48% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.